Novavax Inc (NVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 139,514 | 147,139 | 70,445 | 239,240 | 666,655 |
| Cost of Goods | 30,695 | 22,104 | 21,496 | 15,325 | 14,115 |
| Gross Profit | 108,819 | 125,035 | 48,949 | 223,915 | 652,540 |
| Operating Expenses | 124,944 | 110,909 | 227,463 | 123,170 | 137,142 |
| Operating Income | -15,430 | 14,230 | -178,018 | 101,070 | 515,513 |
| Interest Expense | 4,901 | 5,824 | 5,482 | 5,518 | 5,723 |
| Other Income | 11,825 | 9,497 | -19,536 | 11,902 | 10,056 |
| Pre-tax Income | -8,506 | 17,903 | -203,036 | 107,454 | 519,846 |
| Income Tax | 985 | 376 | -657 | 946 | 1,200 |
| Net Income Continuous | -9,491 | 17,527 | -202,379 | 106,508 | 518,646 |
| Net Income | $-9,491 | $17,527 | $-202,379 | $106,508 | $518,646 |
| EPS Basic Total Ops | -0.06 | 0.09 | -1.25 | 0.66 | 3.22 |
| EPS Basic Continuous Ops | -0.06 | 0.09 | -1.25 | 0.66 | 3.22 |
| EPS Diluted Total Ops | -0.06 | 0.28 | -1.25 | 0.62 | 2.93 |
| EPS Diluted Continuous Ops | -0.06 | 0.27 | -1.25 | 0.60 | 2.92 |
| EPS Diluted Before Non-Recurring Items | N/A | 0.11 | -0.62 | 0.62 | 2.93 |
| EBITDA(a) | $-12,368 | $19,355 | $-171,433 | $108,633 | $523,853 |